Zanzalintinib plus Tecentriq significantly improved overall survival versus Stivarga in previously treated metastatic ...

Colorectal cancer is one of the most common and deadliest cancers worldwide — it’s expected to cause nearly 53,000 deaths in ...

It was "Strike Out Cancer Night" at the Kenosha ballpark. KENOSHA, Wis. - Tuesday night, June 24, was a night to celebrate at ...

Colorectal cancer (CRC) is the second most common cause of death from cancer in the US and the most prevalent malignant tumor ...

I became a colon cancer survivor after my 2020 diagnosis, and I share how my scars, mindset shifts and journaling helped me ...

Exelixis' STELLAR-303 trial shows zanzalintinib plus Tecentriq improved survival in colorectal cancer, with no new safety ...

“Our findings show that exercise is no longer just a quality-of-life intervention for cancer patients that can be offered ...

New trial results reveal zanzalintinib and atezolizumab significantly enhance survival in metastatic colorectal cancer, ...

A three-year exercise program improved survival in colon cancer patients and kept disease at bay, a first-of-its-kind ...

Physical activity for cancer survivors supported by recent research; CAPABLE helps cancer survivors find their physical ...

The exercise prescriptions also prevented other new cancers, like breast and prostate cancer. Many included just three to ...

June is recognized as national cancer survivors month, a time to acknowledge the more than 18 million cancer survivors in the ...